After Trial Deaths, Juno Pivots and Scraps Lead CAR-T Therapy – Xconomy
Xconomy |
After Trial Deaths, Juno Pivots and Scraps Lead CAR–T Therapy
Xconomy Juno Therapeutics said today it would discontinue its experimental CAR–T cell product known as JCAR015. It was once Juno's top candidate as the company raced rivals to be the first to win approval of a new kind of cancer treatment called CAR-T. The … |
